Whitepaper Oct 7, 2026 Finding Common Ground: A Practical Framework for Multi-Stakeholder Co-Creation
Press Release Oct 22, 2026 Lumanity Unveils AI-Enabled Intelligence Platform Engineered to Transform Value Demonstration Across the Lifecycle of a Medicine
Press Release Jul 7, 2026 Lumanity Strengthens Climate Commitment with SBTi (Science Based Targets initiative) Validation For Near-Term Emissions Reduction Targets
Whitepaper Oct 7, 2026 Finding Common Ground: A Practical Framework for Multi-Stakeholder Co-Creation
Press Release Oct 22, 2026 Lumanity Unveils AI-Enabled Intelligence Platform Engineered to Transform Value Demonstration Across the Lifecycle of a Medicine
Press Release Jul 7, 2026 Lumanity Strengthens Climate Commitment with SBTi (Science Based Targets initiative) Validation For Near-Term Emissions Reduction Targets
Whitepaper Mar 17, 2022 Patient Insights Across Rare Diseases: Forging better partnerships through collective advocacy
Whitepaper Feb 7, 2022 Choosing the Right Economic Model to Demonstrate Value for Tumor-Agnostic Therapies
Whitepaper Jan 7, 2022 HTA for Precision Medicines: Evaluating the Impact of Testing Practices, Prognostic Markers, and Other Elements of Value
Whitepaper Nov 30, 2021 Estimating Comparative Effectiveness Using Single-Arm Trials: Overcoming Additional Challenges in the Tumour-Agnostic Space
Whitepaper Sep 24, 2021 A Subscription to Innovation: Could NHS England’s Novel Frameworks for Antimicrobials Be the Future of HTA?
Whitepaper Sep 3, 2021 Heterogeneity & Generalizability: The Core Difficulties in Estimating the Effectiveness of Tumour-Agnostic Drugs in Practice
